Co-Authors
This is a "connection" page, showing publications co-authored by Olga Brawman-Mintzer and James Ballenger.
Connection Strength
0.658
-
Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder. Am J Psychiatry. 1997 May; 154(5):700-2.
Score: 0.147
-
Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study. Am J Psychiatry. 1995 Nov; 152(11):1665-7.
Score: 0.133
-
Somatic symptoms in generalized anxiety disorder with and without comorbid psychiatric disorders. Am J Psychiatry. 1994 Jun; 151(6):930-2.
Score: 0.120
-
Psychiatric comorbidity in patients with generalized anxiety disorder. Am J Psychiatry. 1993 Aug; 150(8):1216-8.
Score: 0.113
-
Sleep Deprivation in social phobia and generalized anxiety disorder. Biol Psychiatry. 1998 Jun 01; 43(11):840-2.
Score: 0.040
-
Sleep deprivation in panic disorder and obsessive-compulsive disorder. Can J Psychiatry. 1997 Nov; 42(9):982-3.
Score: 0.038
-
Recent developments in the psychopharmacology of anxiety disorders. J Consult Clin Psychol. 1996 Aug; 64(4):660-8.
Score: 0.035
-
Bupropion-SR in treatment of social phobia. Depress Anxiety. 2000; 12(2):111-3.
Score: 0.011
-
Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder. J Clin Psychiatry. 1999 May; 60(5):299-301.
Score: 0.011
-
Feasibility of using fMRI to study mothers responding to infant cries. Depress Anxiety. 1999; 10(3):99-104.
Score: 0.010